Which are the causes of Moyamoya?

The exact cause of Moyamoya is not fully understood, but it is currently characterized as a complex condition involving a combination of genetic predisposition and, in some cases, secondary triggers that lead to the progressive narrowing of the internal carotid arteries.

Genetic Factors

While most cases of Moyamoya occur sporadically, about 10% to 15% of patients have a positive family history, suggesting a hereditary component. Researchers have identified the RNF213 gene on chromosome 17 as a major susceptibility gene, particularly in populations of East Asian descent. Mutations in this gene appear to disrupt the normal development and maintenance of blood vessels. Think of RNF213 as a "blueprint" error that makes the delicate internal lining of the brain’s arteries more prone to thickening and blockage over time.

Causes vs. Risk Factors

In medical research, it is vital to distinguish between a "cause" (the underlying mechanism) and a "risk factor" (an association). In Moyamoya, the genetic mutation is a causal factor. Conversely, conditions like Down syndrome, neurofibromatosis type 1, or previous cranial radiation are considered risk factors. These do not "cause" Moyamoya directly, but they create a biological environment where the disease is significantly more likely to manifest.

Current Research and Etiology

Current studies are investigating whether inflammatory processes or autoimmune responses play a role in the rapid progression of Moyamoya. Because the disease involves the "puff of smoke" appearance on angiograms—a compensatory network of fragile, tiny vessels—researchers are also looking at how the body’s angiogenic (vessel-growing) signals go awry. We are still working to understand why the disease affects specific segments of the brain's vasculature while leaving others untouched. By mapping the interaction between the RNF213 gene and environmental stressors, the global medical community aims to move toward earlier diagnostic markers and personalized treatment plans for those living with Moyamoya.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Moyamoya disease


• Orphanet: Moyamoya angiopathy


• Online Mendelian Inheritance in Man (OMIM): #252350 MOYAMOYA DISEASE 1; MYMY1


• Moyamoya Foundation: Understanding the disease